text: <unk>  is an an alpha-adrenergic receptor agonist with a beta-adrenergic receptor inhibitor that is FDA approved for the treatment of glaucoma, ocular hypertension; in patients requiring adjunctive or replacement therapy.   Common adverse reactions include somnolence, allergic conjunctivitis, burning sensation in eye, conjunctival hyperemia, acute follicular conjunctivitis, itching of the eye.
option_0: Brimonidine tartrate and Timolol maleate
option_1: Dorzolamide and Timolol Ophthalmic
option_2: Lidocaine and Hydrocortisone
option_3: Oxymetazoline hydrochloride
option_4: Dorzolamide
option_5: Pilocarpine 
option_6: Brinzolamide
option_7: Ergotamine and caffeine 